Latest News Series A PR Jun 3, 2021Amyl Therapeutics closes €18.3 million Series A financing to develop novel therapies for Amyloidosis. read more
Series A PR Jun 3, 2021Amyl Therapeutics closes €18.3 million Series A financing to develop novel therapies for Amyloidosis. read more